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Abstract ATM (ataxia telangiectasia mutated), the gene
mutated in ataxia telangiectasia, is related to a family of large
phosphatidylinositol 3-kinase domain-containing proteins in-
volved in cell cycle control and DNA repair. We found that
ATM3=3 DT40 cells were more susceptible than wild-type cells
to apoptosis induced not only by ionizing radiation and bleomycin
but also by non-DNA-damaging apoptotic stimuli such as C2-
ceramide. Furthermore, the apoptosis induced by C2-ceramide
and H2O2 was blocked by anti-oxidants, indicating that the
ATM3=3 DT40 cells had a heightened susceptibility to apoptosis
induced by reactive oxygen intermediates (ROI), presumably due
to defective ROI-detoxification activities. In support of this
hypothesis, we found that more ROI were generated in ATM3=3
DT40 cells than in wild-type cells, following treatment with the
above apoptotic stimuli. These results indicate that ATM plays
important roles in the maintenance of the cell homeostasis in
response to oxidative damage.
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1. Introduction
Ataxia telangiectasia (A-T) is an autosomal recessive disor-
der with complex clinical features including progressive cere-
bellar ataxia, oculocutaneous telangiectasias, growth retarda-
tion, cellular and humoral immunode¢ciency, increased
predisposition to lymphoma and leukemias and gonadal ab-
normalities. Cells derived from A-T patients are characterized
by a high level of chromosomal abnormalities, a defect that is
greatly potentiated by ionizing radiation (IR) and by hyper-
sensitivity to IR. In A-T cells, DNA damage fails to induce an
arrest in DNA synthesis (leading to the phenomenon of radio-
resistant DNA synthesis) or an appropriate arrest at the G1/S
or G2/M cell cycle checkpoints, suggesting anomalous cell
cycle regulation as a major underlying cause of the disease
[1,2]. The gene mutated in A-T (designated ATM, ataxia te-
langiectasia mutated) was identi¢ed recently and is a member
of a family of large proteins that have a PI3 kinase domain at
the C-terminus [3]. Several members of this family, including
the yeast proteins Rad3, Mec1 and Tel1, are involved in DNA
repair and cell cycle checkpoint control, further indicating an
important role for ATM in chromosomal maintenance [4,5].
However, the roles for ATM in another important cellular
response to DNA damage, apoptosis, are less clear and con-
£icting results from experiments using cells derived from A-T
patients and ATM-knockout mice have been reported [6^11].
Furthermore, the molecular mechanisms underlying the apop-
tosis of postmitotic cerebellar Purkinje cells in A-T patients in
the absence of DNA damage have remained elusive. Because
DNA-damaging agents such as IR generate reactive oxygen
intermediates (ROI) which damage macromolecules and in-
duce cell death [12], ATM abnormalities may lead to apop-
totic cell death due to oxidative damage. Consistent with this
hypothesis, decreased levels of catalase and increased levels of
lipid hydroperoxides were observed in several A-T cell lines
[13] and increased levels of oxidant-modi¢ed proteins and
lipids were detected in tissues, including brain, of ATM-
knockout mice [14].
To further study the roles played by ATM in the cellular
reaction to oxidative damage, we used an isogenic set of stable
cell lines di¡ering only in their ATM status, which we created
previously from the chicken B cell line DT40. Although these
stable DT40 cell lines, as with most transformed chicken cell
lines, do not express p53, they display many of the character-
istics of A-T cells, most notably a hypersensitivity to IR [15].
We found that ATM3=3 DT40 cells are more susceptible to
apoptotic cell death induced by oxidative stress and that
ATM3=3 DT40 cells show an increased intracellular ROI gen-
eration following oxidative stress. These results indicate that
ATM plays important roles in the maintenance of cell homeo-
stasis in response to oxidative damage.
2. Materials and methods
2.1. Cell culture and analysis of apoptosis
The generation of ATM3=3 mutant clones was described previously
[15]. Wild-type and ATM3=3 DT40 cells were cultured in RPMI1640
medium supplemented with 10% fetal bovine serum (Equitech-Bio.),
1% chicken serum (Sigma), 2 mM L-glutamine, 1035 M L-mercapto-
ethanol and penicillin/streptomycin at 39.5‡C in a humidi¢ed 95% air/
5% CO2 atmosphere. X-ray irradiation was carried out at room tem-
perature using an X-ray irradiator (Hitachi) at 150 kV with 0.5 mm
Cu+0.5 mm Al ¢ltration at a dose of 1.00 Gy/min. Four hours after
treatment with either 4 Gy X-ray irradiation, 100 WM H2O2, 100 WM
C2-ceramide (Sigma) or 100 Wg/ml bleomycin (Wako), the proportion
of apoptotic cells was determined, using an ApoAlert Annexin V
Apoptosis kit (Clontech). Apoptotic morphologic changes were ana-
lyzed by acridine orange staining as described previously [16].
2.2. Analysis of intracellular oxidant production and anti-oxidative
enzyme activities
Intracellular oxidant production was analyzed by £ow cytometry
using a DCFH-DA dye [17]. In brief, 1U106 cells were washed with
HBSS and treated with either 4 Gy X-ray irradiation, 100 Wg/ml
bleomycin or 100 WM C2-ceramide. After 2 h, the cells were stained
with 5 WM DCFH-DA for 30 min at 39.5‡C, then analyzed by £ow
cytometry (FACScan, Becton-Dickinson). The speci¢c activities of
cellular catalase and glutathione peroxidase were measured as de-
scribed previously [18].
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2.3. Karyotypic analysis
For karyotype analysis, colcemid (Gibco-BRL) was added to the
culture medium to a concentration of 0.1 Wg/ml for 3 h, after which
metaphase spreads were placed on glass slides and Giemsa-stained as
described previously [19].
3. Results and discussion
Since markedly decreased clonogenic survival following IR
is a hallmark of cells from A-T patients and was reproduced
in ATM3=3 DT40 cells, we ¢rst analyzed the e¡ects of ATM
disruption on IR-induced apoptosis. To eliminate possible
e¡ects due to decreased clonogenic survival following IR
[15], we monitored the initial phase of apoptosis, using An-
nexin V staining at 4 h following IR and subsequent £ow
cytometric analysis. As shown in Fig. 1, the frequencies of
both spontaneous and IR-induced apoptosis were signi¢cantly
higher in ATM3=3 than in wild-type DT40 cells. In addition,
ATM3=3 DT40 cells were also more susceptible to apoptosis
induced by another double-stranded break (DSB)-inducing
agent, bleomycin. We then studied the susceptibility of
ATM3=3 DT40 cells to apoptosis induced by C2-ceramide
or H2O2, since IR generates ceramides and ROI, which are
possible mediators of apoptosis [12,20^22]. As shown in Fig.
1, ATM3=3 DT40 cells were also more susceptible to apop-
tosis induced by these agents than were wild-type cells. In
addition, when cells were exposed continuously to low levels
of H2O2 using a glucose oxidase system (20 mUnits/ml glu-
cose oxidase and 1 M glucose), the proportions of apoptotic
cells were signi¢cantly higher in ATM3=3 DT40 cells
(57.8 þ 2.20%) than in wild-type DT40 cells (34.9 þ 2.00%).
However, there was no signi¢cant di¡erence between
ATM3=3 and wild-type DT40 cells in the frequency of apop-
tosis following dexamethasone (Fig. 1) or UV irradiation
(data not shown), indicating that ATM3=3 DT40 cells had
increased susceptibility only to some speci¢c types of apop-
totic stimuli. Essentially similar results were obtained in the
analysis of apoptotic morphologic changes with acridine or-
ange staining (data not shown).
We were interested in whether the apoptosis that followed
C2-ceramide and H2O2 treatment induced DNA damage to
trigger apoptosis. As shown in Fig. 2, IR and bleomycin in-
duced chromosomal breaks, the frequencies of which were
highly elevated in ATM3=3 DT40 cells, as reported previously
[15]. However, C2-ceramide did not induce signi¢cant chro-
mosomal breaks. (We could not determine the extent of chro-
mosome breaks with H2O2 for technical reasons.) It is there-
fore unlikely that the apoptosis induced by C2-ceramide was
due to DNA damage.
ATM3=3 DT40 cells were more susceptible to H2O2-in-
duced apoptosis than wild-type cells (Fig. 1), and ROI is
implicated in ceramide-induced apoptosis [23,24]. The results
of a recent study further suggest that ATM-de¢cient cells are
more susceptible to oxidative damage than wild-type cells [14].
Taken together, these results raise the interesting possibility
that more ROI are generated in ATM-de¢cient cells due to a
defective ROI-detoxi¢cation mechanism. We therefore deter-
mined the amount of ROI generation in ATM3=3 and wild-
type DT40 cells, following apoptotic stimuli (IR, bleomycin,
and C2-ceramide): 2 h after treatment with these agents, intra-
cellular oxidant products were measured using DCFH-DA
dye staining. As shown in Fig. 3, intracellular oxidant prod-
ucts were signi¢cantly increased in ATM3=3 DT40 cells com-
pared with wild-type DT40 cells. Furthermore, the addition of
catalase (1 mg/ml) or N-acetyl cysteine (5 mM) to cell cultures
stimulated with C2-ceramide and H2O2 inhibited not only
Table 1
E¡ect of anti-oxidants on apoptosis in wild-type and ATM3=3 DT40 cells
Treatment Wild-type ATM3=3
None +Catalase +NAC None +Catalase +NAC
Control 6.6 þ 0.46 6.5 þ 1.78 5.7 þ 0.77 9.5 þ 1.11 9.5 þ 0.35 8.7 þ 1.15
X-ray 36.4 þ 3.21 13.3 þ 0.68 19.0 þ 0.58 58.3 þ 2.45 27.3 þ 2.58 38.5 þ 4.11
Bleomycin 29.2 þ 3.28 12.1 þ 0.93 17.1 þ 1.53 59.2 þ 1.86 28.7 þ 1.95 41.2 þ 2.25
C2-ceramide 35.2 þ 2.41 7.1 þ 0.90 15.3 þ 0.96 49.4 þ 3.56 8.4 þ 0.76 25.2 þ 1.17
H2O2 28.1 þ 0.91 7.3 þ 0.92 7.2 þ 0.87 44.9 þ 0.92 8.6 þ 0.65 8.5 þ 0.64
Wild-type and ATM3=3 DT40 cells had received X-ray irradiation (4 Gy) or were treated with bleomycin (100 Wg/ml), C2-ceramide (100 WM)
or H2O2 (100 WM) with or without anti-oxidants (catalase: 1 mg/ml, NAC: 5 mM). After 4 h, the cells were stained with Annexin V for 15
min, and then analyzed with £ow cytometry. Data are expressed as mean þ S.D. (n = 3). Similar results were obtained in two consecutive experi-
ments.
Fig. 1. Flow cytometric analysis of apoptosis by Annexin V stain-
ing. Wild-type (E) and ATM3=3 (F) DT40 cells were treated with
either IR (4 Gy), bleomycin (100 Wg/ml), C2-ceramide (100 WM),
H2O2 (100 WM) or dexamethasone (1038 M). After 4 h, the cells
were stained with Annexin V for 15 min, then analyzed using £ow
cytometry. Data are expressed as mean þ S.D. (n = 3). *P6 0.05,
treated ATM3=3 cells compared with wild-type DT40 cells. Similar
results were obtained in two consecutive experiments with two dif-
ferent ATM3=3 DT40 clones.
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intracellular oxidant production (data not shown) but also
apoptosis (Table 1), indicating that ROI are important medi-
ators for the apoptosis induced by these agents. However,
while the addition of these anti-oxidants to cell cultures stimu-
lated with IR and bleomycin inhibited intracellular oxidant
production (data not shown), these anti-oxidants were only
partially e¡ective in inhibiting the apoptosis induced by these
agents (Table 1). To study further possible mechanisms for
the increased susceptibility of ATM3=3 DT40 cells to oxida-
tive stress, we measured catalase and glutathione peroxidase
activities in wild-type and ATM3=3 DT40 cells. As shown in
Table 2, reduced levels of catalase activity were observed in
ATM3=3 DT40 cells in agreement with the study on cells
derived from A-T patients [13], though there was no signi¢-
cant di¡erence in glutathione peroxidase activity between
wild-type and ATM3=3 DT40 cells.
Although markedly decreased clonogenic survival following
IR is consistently seen in cells from A-T patients, con£icting
results on IR-induced apoptosis have been reported with cells
derived from A-T patients and ATM-knockout mice [6^11].
Recently, A-T cells have been shown to be more susceptible to
IR-induced apoptosis due to enhanced ceramide generation
[25]. In the present study, we have shown that ATM3=3
DT40 cells are more susceptible than wild-type cells to apop-
tosis induced not only by IR and bleomycin but also by C2-
ceramide (Fig. 1). We further showed that, unlike IR and
bleomycin, which induce DSB, C2-ceramide does not induce
signi¢cant DSB (Fig. 2), indicating that ATM3=3 DT40 cells
are also more sensitive to the apoptosis induced by non-DNA-
damaging apoptotic stimuli. Although the precise mechanism
underlying ceramide-induced apoptosis is still poorly de¢ned
[26,27], ROI are candidate mediators [23,24]. In support of
this hypothesis, we found that ATM3=3 DT40 cells also are
more susceptible to H2O2-induced apoptosis (Fig. 1), and that
the apoptosis induced by C2-ceramide and H2O2 is completely
blocked by anti-oxidants such as catalase or N-acetyl cysteine
(Table 1). Several groups of investigators recently reported
evidence that ATM-de¢cient cells are more susceptible than
wild-type cells to oxidative damage [13,14,28]. These results
raise the interesting possibility that ATM is involved in ROI-
detoxi¢cation. In support of this hypothesis, we found that
more ROI are generated in ATM3=3 DT40 cells than in wild-
type DT40 cells, following treatment with several apoptotic
stimuli (Fig. 3), and that a reduced level of catalase activity
Fig. 2. Frequencies of chromosomal aberrations following apoptotic
stimuli. Wild-type (E) and ATM3=3 (F) DT40 cells were treated
with colcemid for 3 h following treatment with either IR (4 Gy),
bleomycin (100 Wg/ml), or C2-ceramide (100 WM). Data are pre-
sented as macrochromosomal (1^5 and Z) aberrations per 100 meta-
phase spreads, and expressed as mean þ S.D. (n = 3).
Table 2
Anti-oxidative enzyme activities in wild-type and ATM3=3 DT40
cells
Wild-type ATM3=3
Catalase (Units/mg protein) 1.6 þ 0.92 0.19 þ 0.15*
Glutathione peroxidase
(mUnits/mg protein)
16.7 þ 0.42 16.7 þ 0.07
Wild-type and ATM3=3 DT40 cells were washed with PBS(3) twice
and suspended in PIPA bu¡er (0.01% digitonin, 0.25% sodium chol-
ate). Catalase and glutathione peroxidase activities in cells were de-
termined as described in Section 2. Data are expressed as
mean þ S.D. (n = 3). *P6 0.05, treated compared to wild-type DT40
cells. Similar results were obtained in two consecutive experiments.
Fig. 3. Production of intracellular oxidants in response to apoptotic
stimuli. Wild-type (E) and ATM3=3 (F) DT40 cells were treated
with either IR (4 Gy), bleomycin (100 Wg/ml), C2-ceramide (100
WM) or dexamethasone (1038 M). After 2 h, the cells were stained
with DCFH-DA (5 WM) for 30 min at 39.5‡C, then analyzed using
£ow cytometry. Data are expressed as mean þ S.D. (n = 3).
*P6 0.05, treated ATM3=3 cells compared with wild-type DT40
cells. Similar results were obtained in two consecutive experiments
with two di¡erent ATM3=3 DT40 clones.
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was observed in ATM3=3 DT40 cells (Table 2). These results
are also consistent with those of a recent study that showed
increased levels of oxidant-modi¢ed products, decreased levels
of catalase and enhanced heme oxygenase activity in ATM-
de¢cient cells and tissues [13,14]. However, at the present
time, we cannot exclude the possibility that ATM also func-
tions in anti-apoptotic pathways. Further investigation will be
required to de¢ne how ATM functions in the cellular response
to oxidative stress.
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